QMA

Alnylam Pharmaceuticals, Inc. (ALNY) — QMA analysis

Sector: Healthcare · Market cap: $42.6B · Price: $224,03 · Data as of 2026-10-24

62
/100
B
Composite grade
Higher score than 95% of 22,734 tracked stocks

Alnylam Pharmaceuticals, Inc. has an above-average composite score of 62/100, higher score than 95% of 22,734 tracked stocks. The highest-scoring layer is Fundamental value; the lowest is Insider activity.

Analytical score, not investment advice. No score is an instruction or a guarantee. Past performance ≠ future results.

What 13 data layers say about ALNY

The composite fuses insiders, congressional trades, institutional 13F positions, fundamentals, momentum, seasonality and more into a single number.

LayerScore
Fundamental value (FVS)87/100
Earnings quality (EQS)70/100
Technical trend (TSS)46/100
Relative strength (RS)41/100
Momentum (USS)36/100
Insider activity (IAS)13/100
Off-exchange trading (FINRA) / large flows (WHS)29/100
Institutional 13F (IFS)60/100
Options flow (OFS)74/100
Congressional trades (PTS)35/100
News sentiment (NSS)59/100
Analysts / transcripts (ATS)85/100
Catalysts (XS)85/100

What does the QMA model currently show for Alnylam Pharmaceuticals, Inc.?

The composite score is a research starting point, not an instruction. What matters is layer confluence — whether the layers point in the same direction.

For ALNY the layers diverge — some score high (Fundamental value), others low (Insider activity). The divergence is itself information: the model does not give a clear-cut picture. The score is an input into your own research, not a recommendation.

ALNY insider & smart money activity

Over the recent period we record 1 reported insider purchases and 7 sales for ALNY: mixed picture. A description of the data layer, not an instruction.

ALNY seasonality

The historically strong window for ALNY was June 1–28 with a hit rate of 67% and an average move of 5.9% (21 years of history).

Historical data does not guarantee future results.

How ALNY compares

Similar stocks from the same sector:

Frequently asked questions

What is the composite score for ALNY stock?

62/100 (B) — Data as of 2026-10-24.

Are insiders buying ALNY stock?

Over the recent period, reported: purchases 1, sales 7 (purchases $1.3M, sales $1.41M). Insider activity: mixed picture — a description of reported data, not a trade instruction.

Where can I see live ALNY data?

Live ALNY data and the full screener are part of full access. Registration is free with no card — trial full access, then the free plan with a delayed data sample.

Free registration, no card — trial full access, then the free plan

Open ALNY detail →

Data from SEC and public markets. QMA is an analytical tool, not a registered investment advisor. No content on this page is investment advice or an instruction to buy or sell. Past performance does not guarantee future results.

⚠️ Important Notice: QMA is an analytical and educational tool, not investment advice. Scores, detections and ratings are descriptive, not buy/sell instructions. QMA is not a registered investment advisor (SEC / FINRA / MiFID II / ČNB). Consult a licensed financial advisor before any investment. Past performance does not guarantee future results; all investments carry the risk of capital loss.

Operator: Jaroslav Vojtášek · IČO: 48783447 · Place of business: U Jízdárny 577, 747 64 Velká Polom, Czech Republic · Register: Sole trader registered in the Czech Trade Licensing Register · E-mail: [email protected]